Companies House · 01547204

SANDOZ LIMITED

UK registered company, private limited company, incorporated 24 Feb 1981.

Active
50
Public contracts
0
Spend payments
Total spend

SANDOZ LIMITED is a UK company registered at Companies House under number 01547204. This page links its registry record to its activity in UK public procurement — the contracts it has been awarded and the transparency-spend payments recorded against it.

Companies House record

Company number
01547204
Status
Active
Company type
Private Limited Company
Incorporated
24 Feb 1981
Country of origin
United Kingdom
Registered office
MAXIS 1, BRACKNELL, RG12 1RF, UNITED KINGDOM
Nature of business (SIC)
21100 - Manufacture of basic pharmaceutical products
Accounts category
FULL
View source on data.gov.uk

Public sector contracts

Contract awards linked to SANDOZ LIMITED.

ProcurementBuyerAwardedValue
Generic Drugs - Tablets & CapsulesVelindre NHS Trust, NHS Wales Shared Services Partnership - Procurement Services ( on behalf of All LHB's and Trusts )
NHS National Generic Pharmaceuticals Interim 2 2020The NHS Commissioning Board (operating under the name of NHS England)
Medicinal Products and Pharma Funded Homecare Services (5315742) - Pre - Market EngagementRegional Business Services Organisation Procurement and Logistics Service
NP40923 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease MedicinesThe Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority")
NHS Framework Agreement for Branded Medicines – Tranche A London and South of England and Adult Influenza (National) - 01 September 2025NHS England
NHS National Generic Pharmaceuticals Wave 15bNHS England
Medicinal Products Dynamic Purchasing System (131864)Regional Business Services Organisation, Procurement and Logistics Service
Medicinal Products Dynamic Purchasing System (131864)Regional Business Services Organisation, Procurement and Logistics Service
Medicinal Products Dynamic Purchasing System (131864)Procurement & Logistics Service
Medicinal Products Dynamic Purchasing System (131864)Procurement and Logistics Service
NHS National Generic Pharmaceuticals Wave 15bNHS England
NHS Framework Agreement for Branded Medicines – Tranche B - NOFE & MAE and Eculizumab & Ravulizumab for London & SOFE - 01 September 2025NHS England
Dynamic Purchasing System (DPS) for the Supply of Antibiotics and IV FluidsDepartment of Health and Social Care
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Medicinal Products and Pharma Funded Homecare ServicesProcurement and Logistics Service
Medicinal Products and Pharma Funded Homecare Services (5315742) - Pre - Market EngagementRegional Business Services Organisation Procurement and Logistics Service
NHS National Framework for Medical Retinal Vascular Treatments - 1 December 2025NHS England North East & Yorkshire30 Jul 2025£782.9m
NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025NHS England30 Jun 2025£986.3m
NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza NationalNHS England24 Jun 2025£261.9m
NHS Framework Agreement for Branded Medicines - Proprietary Category TenderNHS England24 Mar 2025£1.2bn
CM/TNS/24/5711 -NHS Framework for the supply of UstekinumabNHS England12 Aug 2024£230m
NHS National Framework for Transition products commencing 1 May 2024NHS ENGLAND15 Apr 2024£7.6m
NHS Framework Agreement for Branded Medicines - National Tender - 1 May 2024NHS England4 Apr 2024£1bn
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 1)NHS England4 Mar 2024£1
NHS Branded Medicines Framework for North of England and Midlands and East - 1 March 2024NHS England26 Jan 2024£688m
NHS South of England Branded Medicines - Tranche A - September 2023NHS England17 Jul 2023£249.8m
NHS London Branded Medicines - Tranche B - September 2023NHS England13 Jul 2023£231.1m
NHS National Generic Pharmaceuticals Wave 14bATAMIS LTD6 Jul 2023£428.2m
Dynamic Purchasing System (DPS) for the Supply of Antibiotics and IV Fluids (Quarterly Notice)Department of Health and Social Care (DHSC)18 May 2023£6m
NHS National Generics Pharmaceuticals Transition 2023_1NHS england4 May 2023£57.6m
NHS Framework Agreement-Branded Medicines - National Proprietary PharmaceuticalsNHS England23 Apr 2023£304.5m
NHS National Framework Agreement for the supply of Adalimumab Injection 1 April 2023NHS England3 Mar 2023£264m
NHS Midland & East Branded Medicines, Tranche B & Annual TrancheNHS England13 Feb 2023£480.4m
NHS Framework for North of England Branded Medicines Tranche A & Annual TrancheNHS England8 Feb 2023£262m
NHS National Generic Pharmaceuticals Wave 14aNHS England14 Dec 2022£208m
NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement18 Jul 2022£39.6m
NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement18 Jul 2022£39.6m
NHS Framework Agreement for South of England Branded - Tranche B and AnnualNHS England14 Jul 2022£338.7m
NHS Framework Agreement for London, Branded Medicines - Tranche A and AnnualNHS England14 Jul 2022£153.8m
NHS Framework Agreement for Branded medicines - NationalNHS England15 May 2022£526m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for the North of England, Branded MedicineNHS England7 Feb 2022£238.9m
NHS Framework for Midlands and East, Branded Medicines - Tranche A and AnnualNHS England7 Feb 2022£216.1m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS National Generic Pharmaceuticals Wave 13ATAMIS LTD30 Nov 2021£469.7m
NHS Framework Agreement for Branded Medicines - NationalNHS England26 Sept 2021£95.2m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m
NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England18 Aug 2021£558.5m

Supplier identities

How this company appears as a supplier across the data.

FAQs about SANDOZ LIMITED

Is SANDOZ LIMITED an active company?

SANDOZ LIMITED (company number 01547204) is recorded as "Active", incorporated on 24 Feb 1981.

What does SANDOZ LIMITED do?

Its Companies House nature-of-business (SIC) is: 21100 - Manufacture of basic pharmaceutical products.

Has SANDOZ LIMITED won UK public-sector contracts?

Yes — 50 public-sector contract awards are linked to this company in our data.

Where is SANDOZ LIMITED based?

Its registered office is MAXIS 1, BRACKNELL, RG12 1RF, UNITED KINGDOM.

Understand any company's public-sector footprint

Enable links Companies House to live procurement and spend data — see contracts, buyers and payments for any UK supplier.

Get in touch with Enable